During the past decade, Medical Center University of Muenster conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "Medical Center University of Muenster" are "Acute Lymphoblastic Leukemia" (1 trials), "Acute Myeloid Leukemia" (1 trials), "Gastrointestinal Diseases" (1 trials), "Hematologic Malignancies" (1 trials) and "Non-Hodgkin Lymphoma" (1 trials). Many other conditions were trialed in "Medical Center University of Muenster" in a lesser frequency.

Most popular intervention types in "Medical Center University of Muenster" are "Drug" (3 trials), "Procedure" (3 trials) and "Device" (2 trials). Other intervention types were less common.

The name of intervention was led by "CD3/CD19 depletion on CliniMACS" (1 trials), "Double-balloon procedure (DBE)" (1 trials), "Fludarabine" (1 trials), "Fludarabine, Thiotepa, Melphalan, Thymoglobuline (ATG)" (1 trials) and "Melphalan" (1 trials). Other intervention names were less common.

The vast majority of trials in "Medical Center University of Muenster" are 5 trials for "All" genders.

Currently, there are NaN active trials in "Medical Center University of Muenster". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Medical Center University of Muenster, undefined suspended trials, and 2 terminated clinical trials to date.

Out of the total trials that were conducted in Medical Center University of Muenster, 2 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".